RYTHM (RYM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Mar, 2026Executive summary
Revenue for Q4 2025 reached $10.7 million, a 164% increase from the prior quarter, with gross profit at $8.0 million (75% margin).
Full-year 2025 revenue was $17.3 million, with significant brand acquisitions and expansion into over 6,000 retail locations across 18 states.
Licensing revenue in Q4 was $7.0 million, driven by recent brand acquisitions, contributing to high gross margins.
Señorita THC Margaritas launched in over 800 Circle K stores and at Chicago's United Center, marking a major U.S. arena debut for THC beverages.
Financial highlights
Q4 2025 gross profit was $8.0 million (75% of revenue), up from $1.4 million (34%) in the prior quarter.
Operating loss for Q4 was $12.9 million, primarily due to an $8.5 million non-cash impairment charge.
Full-year operating loss from continuing operations was $32.3 million; net loss for the year was $33.3 million.
Cash balance at year-end was $32.2 million.
Outlook and guidance
Management expects continued momentum for hemp-derived beverages despite regulatory headwinds, emphasizing long-term strategic value in owning leading U.S. brands.
Forward-looking statements highlight risks related to federal prohibition on hemp-derived THC products, with potential impact after November 2026.
Latest events from RYTHM
- Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and equity plan amendment.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and equity plan expansion.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and major equity plan amendments.RYM
Proxy Filing1 Dec 2025 - Quorum for the August 2024 Annual Meeting is now one-third of outstanding shares.RYM
Proxy Filing1 Dec 2025 - Equity line offering seeks up to $15M amid financial challenges and industry risks.RYM
Registration Filing29 Nov 2025 - Registering 4.7M shares for resale to raise up to $15M amid ongoing losses and dilution risk.RYM
Registration Filing28 Nov 2025 - Q3 2025 revenue hit $4.0M, nearly doubling sequentially as THC beverages expanded in retail.RYM
Q3 20257 Nov 2025